1. Home
  2. NVGS vs STOK Comparison

NVGS vs STOK Comparison

Compare NVGS & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVGS
  • STOK
  • Stock Information
  • Founded
  • NVGS 1997
  • STOK 2014
  • Country
  • NVGS United Kingdom
  • STOK United States
  • Employees
  • NVGS N/A
  • STOK N/A
  • Industry
  • NVGS Marine Transportation
  • STOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • NVGS Consumer Discretionary
  • STOK Health Care
  • Exchange
  • NVGS Nasdaq
  • STOK Nasdaq
  • Market Cap
  • NVGS 1.1B
  • STOK 1.3B
  • IPO Year
  • NVGS N/A
  • STOK 2019
  • Fundamental
  • Price
  • NVGS $14.82
  • STOK $30.50
  • Analyst Decision
  • NVGS Strong Buy
  • STOK Strong Buy
  • Analyst Count
  • NVGS 3
  • STOK 6
  • Target Price
  • NVGS $22.33
  • STOK $26.60
  • AVG Volume (30 Days)
  • NVGS 251.6K
  • STOK 1.2M
  • Earning Date
  • NVGS 11-05-2025
  • STOK 11-04-2025
  • Dividend Yield
  • NVGS 1.34%
  • STOK N/A
  • EPS Growth
  • NVGS 12.51
  • STOK N/A
  • EPS
  • NVGS 1.26
  • STOK 0.91
  • Revenue
  • NVGS $566,889,000.00
  • STOK $199,893,000.00
  • Revenue This Year
  • NVGS $3.67
  • STOK $416.54
  • Revenue Next Year
  • NVGS $0.11
  • STOK N/A
  • P/E Ratio
  • NVGS $11.93
  • STOK $33.59
  • Revenue Growth
  • NVGS 1.19
  • STOK 1218.82
  • 52 Week Low
  • NVGS $10.55
  • STOK $5.35
  • 52 Week High
  • NVGS $17.53
  • STOK $32.40
  • Technical
  • Relative Strength Index (RSI)
  • NVGS 33.46
  • STOK 79.57
  • Support Level
  • NVGS $14.87
  • STOK $25.95
  • Resistance Level
  • NVGS $15.77
  • STOK $27.91
  • Average True Range (ATR)
  • NVGS 0.33
  • STOK 1.12
  • MACD
  • NVGS -0.16
  • STOK 0.15
  • Stochastic Oscillator
  • NVGS 5.59
  • STOK 88.82

About NVGS Navigator Holdings Ltd. (Marshall Islands)

Navigator Holdings Ltd owns and operates liquefied gas carriers, which include a fleet of handysize liquefied gas carriers. The company also owns a share in an ethylene export marine terminal at Morgan's Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture). Company play a vital role in theglobalised liquefied gas supply chain, providing gas transportation solutions for energy companies, industrial users and commodity traders.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: